Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Plus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year